Medical Coatings Companies

The medical coating market is expected to grow at a CAGR of 9.6%, reaching USD 15,813.6 million by 2030 from USD 9,983.0 million in 2025. Drivers such as rising healthcare expenditure, an expanding geriatric population, increasing prevalence of chronic diseases, and growing demand for minimally invasive surgeries are significantly propelling market growth.

Medical Coating Companies

Key global players in the medical coating market, including Hydromer (US), DSM-Firmenich (Netherlands), Surmodics (US), Biocoat Incorporated (US), AST Products Inc (US), Covalon Technologies (Canada), Freudenberg Medical (US), Harland Medical Systems, Inc (US), Merit Medical Systems (US), Applied Medical Coatings (US), PPG Industries, Inc. (US), and The Sherwin-Williams Company (US), have a strong presence in their regions and are pursuing geographic diversification to expand their businesses. They are aiming to increase their market share through new product launches, mergers, and expansions.

To know about the assumptions considered for the study download the pdf brochure

Hydromer

Hydromer is a leading global provider of hydrophilic medical coatings and biopolymers, offering a comprehensive line of products for various medical applications. Hydromer's business operates through two divisions: polymer research and medical products. The polymer research division focuses on research and development services; this segment generates contract revenue and royalties from an extensive portfolio of medical coatings, including primers, thromboresistant coatings, coatings that keep devices hydrophilic after insertion, and coatings that promote cell growth. The company serves the medical coating market across the urology, cardiology, and neurovascular sectors. Hydromer licenses its proprietary lubricious coating technologies, enabling customers to leverage innovative coating solutions. The company also provides stand-still agreements that allow customers to evaluate product-process feasibility, test market products, and potentially enter long-term licensing, supply, or support agreements. Geographically, Hydromer operates in North America, Europe, and Asia Pacific, with most revenues coming from the US. The company is headquartered in Concord, North Carolina, and previously operated a manufacturing facility in Branchburg, New Jersey, which has now been relocated to Concord.

DSM Firmenich

DSM Firmenich, a science-based global company, operates through three segments: Taste, Texture & Health; Health, Nutrition & Care; and Animal Nutrition & Health. The company offers a wide range of solutions related to nutrition, health, and sustainable living. The Taste, Texture & Health segment, through its division DSM Biomedical, provides medical coatings, drug delivery platforms, and various biomedical materials, including bioceramics, biomedical polyethylenes, biomedical polyurethanes, collagen, and ophthalmic biomaterials. DSM-Firmenich operates globally, supporting customers in the medical coating market through its extensive network of over 110 commercial production facilities in more than 40 countries. Major manufacturing sites for DSM Biomedical are located in the United States, Europe, and Asia, with significant facilities in countries such as the Netherlands, the US, and Japan. The company's innovation centers focus on promising growth areas, such as DSM Biomedical, developing disruptive material concepts for medical devices that address previously unmet clinical needs. One example is the production of low-cost, durable, and minimally invasive replacement heart valves. With a focus on innovation, customer satisfaction, and product development, DSM Firmenich has numerous opportunities for growth and momentum in the medical coating market.

Surmodics

Surmodics Inc. is a leading provider of surface modification coating technologies and in vitro diagnostic products in the medical device and in vitro diagnostics market. Surmodics medical coatings include lubricious hydrophilic coatings, hemocompatible hydrophilic coatings, and drug delivery coatings designed to enhance the performance and safety of medical devices. Moreover, Surmodics is committed to innovation and develops and commercializes its surface modification coating technologies through licensing agreements with third-party medical device manufacturers. The company protects its intellectual property with a strong patent portfolio. Surmodics' operations are mainly based in the United States, where it has its headquarters and manufacturing facility in Eden Prairie, Minnesota, along with a limited presence in Europe, including a subsidiary in the United Kingdom. Its robust global presence serves various customers in the medical device industry, and the organization continually develops medical coatings for a wide range of applications, such as cardiovascular, orthopedic, and neurovascular devices, among others. Surmodics' dedication to innovation and customer satisfaction ensures it remains a trusted partner for medical device manufacturers worldwide.

Market Ranking

The medical coating market is highly competitive, with five main players collectively holding 35-40% of the total market share. It is characterized by intense competition and innovation, and the major players stand out due to their technical expertise, global presence, and diversified product portfolios. The leading companies include Hydromer, DSM Firmenich, Surmodics, Biocoat Incorporated, and AST Products. Hydromer specializes in developing advanced hydrophilic and antimicrobial coatings that significantly improve the performance of devices marketed in developing countries like India and China. DSM Firmenich has built a strong reputation for coating biocompatible materials by providing precise coatings that meet strict regulatory standards, supporting expansion in Brazil and other emerging economies. Surmodics focuses on lubricious and drug-eluting coatings designed for diagnostics and therapeutics with complex needs, backed by robust R&D efforts that enable them to deliver comprehensive solutions worldwide. Biocoat Incorporated offers custom hydrophilic coatings that highlight their innovative capacity with flexible, biocompatible, and durable options, especially in cost-sensitive markets such as South Korea. AST Products provides durable, high-performance products that support innovation across various medical applications, particularly through strategic partnerships in Asia-Pacific markets. Together, these companies will continue to propel market growth through innovation, adherence to regulatory standards, and development of products tailored to client-specific needs. The industry is experiencing significant growth driven by healthcare advancements, and these firms are well-positioned to address capacity costs and capitalize on the rising demand for new, advanced healthcare solutions to support global infrastructure expansion.

Related Reports:

Medical Coating Market by Coating Type (Active, Passive), By Material (Polymers, Metals), By Application (Medical Devices, Medical Implants, Medical Equipment & Tools), By Region – Global Forecast to 2030